Cancer Immunology Immunotherapy, ISSN 0340-7004, 2010, Volume 59, Issue 10, pp. 1573 - 1582
Dendritic cells (DCs) are central players of the immune response. To date, DC-based immunotherapy is explored worldwide in clinical vaccination trials with...
Plasmacytoid dendritic cells | Immunology | Medicine & Public Health | Myeloid dendritic cells | Toll-like receptors | Oncology | Cancer Research | Dendritic cell vaccination | COLONY-STIMULATING FACTOR | IMMUNOLOGY | CPG DNA | BREAST-CANCER | METASTATIC MELANOMA | HUMAN PERIPHERAL-BLOOD | MESSENGER-RNA | ONCOLOGY | IMMUNE-RESPONSES | IN-VIVO | T-LYMPHOCYTES | ANTIGEN | Neoplasms - therapy | Neoplasms - immunology | Dendritic Cells - immunology | Humans | Immunotherapy | Toll-Like Receptors - metabolism | Dendritic Cells - transplantation | Lymphocyte Subsets - immunology | Antigens | Care and treatment | Dendritic cells | Vaccination | Cancer
Plasmacytoid dendritic cells | Immunology | Medicine & Public Health | Myeloid dendritic cells | Toll-like receptors | Oncology | Cancer Research | Dendritic cell vaccination | COLONY-STIMULATING FACTOR | IMMUNOLOGY | CPG DNA | BREAST-CANCER | METASTATIC MELANOMA | HUMAN PERIPHERAL-BLOOD | MESSENGER-RNA | ONCOLOGY | IMMUNE-RESPONSES | IN-VIVO | T-LYMPHOCYTES | ANTIGEN | Neoplasms - therapy | Neoplasms - immunology | Dendritic Cells - immunology | Humans | Immunotherapy | Toll-Like Receptors - metabolism | Dendritic Cells - transplantation | Lymphocyte Subsets - immunology | Antigens | Care and treatment | Dendritic cells | Vaccination | Cancer
Journal Article
Expert Review of Vaccines, ISSN 1476-0584, 12/2019, pp. 1 - 17
Journal Article
Nature, ISSN 0028-0836, 2014, Volume 515, Issue 7525, pp. 138 - 142
The isolation of human monoclonal antibodies is providing important insights into the specificities that underlie broad neutralization of HIV-1 (reviewed in...
B-CELLS | SPECIFICITIES | MULTIDISCIPLINARY SCIENCES | SERA | IMMUNODEFICIENCY-VIRUS TYPE-1 | ENV TRIMERS | VULNERABILITY | GP120 | HUMAN MONOCLONAL-ANTIBODIES | CLEAVAGE | DEPENDENT EPITOPE | Immunoglobulin Fab Fragments - ultrastructure | Antibody Specificity | Epitope Mapping | HIV Envelope Protein gp41 - immunology | Humans | AIDS Vaccines - immunology | Molecular Sequence Data | Leukocytes, Mononuclear | HIV Envelope Protein gp41 - chemistry | Virus Internalization - drug effects | Epitopes - immunology | HIV Envelope Protein gp120 - immunology | Antibodies, Neutralizing - immunology | Receptors, CCR5 - metabolism | HIV Antibodies - immunology | Conserved Sequence | Inhibitory Concentration 50 | HIV Envelope Protein gp120 - chemistry | HIV Antibodies - pharmacology | Antibodies, Monoclonal - chemistry | Antibodies, Monoclonal - immunology | Cell Line | Immunoglobulin Fab Fragments - genetics | HIV-1 - drug effects | Antibodies, Monoclonal - pharmacology | Models, Molecular | Antibodies, Neutralizing - pharmacology | Antibody Affinity | Antibodies, Neutralizing - genetics | HIV Antibodies - chemistry | AIDS Vaccines - chemistry | Antibodies, Monoclonal - genetics | HIV-1 - immunology | Antibodies, Neutralizing - chemistry | Immunoglobulin Fab Fragments - chemistry | Cell Membrane - virology | Epitopes - chemistry | HIV Antibodies - genetics | Immunoglobulin Fab Fragments - immunology | CD4 Antigens - metabolism | Viral antibodies | Care and treatment | Antibodies | Physiological aspects | Genetic aspects | Research | HIV infection | Antigenic determinants | Amino acids | Mutation | Vaccines | Human immunodeficiency virus--HIV | Binding sites | Index Medicus
B-CELLS | SPECIFICITIES | MULTIDISCIPLINARY SCIENCES | SERA | IMMUNODEFICIENCY-VIRUS TYPE-1 | ENV TRIMERS | VULNERABILITY | GP120 | HUMAN MONOCLONAL-ANTIBODIES | CLEAVAGE | DEPENDENT EPITOPE | Immunoglobulin Fab Fragments - ultrastructure | Antibody Specificity | Epitope Mapping | HIV Envelope Protein gp41 - immunology | Humans | AIDS Vaccines - immunology | Molecular Sequence Data | Leukocytes, Mononuclear | HIV Envelope Protein gp41 - chemistry | Virus Internalization - drug effects | Epitopes - immunology | HIV Envelope Protein gp120 - immunology | Antibodies, Neutralizing - immunology | Receptors, CCR5 - metabolism | HIV Antibodies - immunology | Conserved Sequence | Inhibitory Concentration 50 | HIV Envelope Protein gp120 - chemistry | HIV Antibodies - pharmacology | Antibodies, Monoclonal - chemistry | Antibodies, Monoclonal - immunology | Cell Line | Immunoglobulin Fab Fragments - genetics | HIV-1 - drug effects | Antibodies, Monoclonal - pharmacology | Models, Molecular | Antibodies, Neutralizing - pharmacology | Antibody Affinity | Antibodies, Neutralizing - genetics | HIV Antibodies - chemistry | AIDS Vaccines - chemistry | Antibodies, Monoclonal - genetics | HIV-1 - immunology | Antibodies, Neutralizing - chemistry | Immunoglobulin Fab Fragments - chemistry | Cell Membrane - virology | Epitopes - chemistry | HIV Antibodies - genetics | Immunoglobulin Fab Fragments - immunology | CD4 Antigens - metabolism | Viral antibodies | Care and treatment | Antibodies | Physiological aspects | Genetic aspects | Research | HIV infection | Antigenic determinants | Amino acids | Mutation | Vaccines | Human immunodeficiency virus--HIV | Binding sites | Index Medicus
Journal Article
Immunity, ISSN 1074-7613, 05/2014, Volume 40, Issue 5, pp. 669 - 680
All previously characterized broadly neutralizing antibodies to the HIV-1 envelope glycoprotein (Env) target one of four major sites of vulnerability. Here, we...
REFINEMENT | SITE | POTENT NEUTRALIZATION | RECOGNITION | BROADLY NEUTRALIZING ANTIBODIES | GP41 | IMMUNOLOGY | IDENTIFICATION | COMBINATION | BINDING | Cell Line | HIV Infections - prevention & control | Binding Sites, Antibody - immunology | env Gene Products, Human Immunodeficiency Virus - immunology | HIV Envelope Protein gp41 - immunology | Humans | Crystallization | HIV Envelope Protein gp41 - metabolism | Molecular Sequence Data | Antibodies, Neutralizing - ultrastructure | Crystallography, X-Ray | Polysaccharides - immunology | Epitopes - immunology | HIV Antibodies - ultrastructure | HIV Envelope Protein gp120 - immunology | Antibodies, Monoclonal - ultrastructure | HIV Infections - immunology | Antibodies, Neutralizing - immunology | HIV-1 - immunology | HIV Antibodies - immunology | HEK293 Cells | Protein Structure, Quaternary | Antibodies, Monoclonal - immunology | Monoclonal antibodies | Polysaccharides | HIV (Viruses) | Antigenic determinants | Proteins | Medical research | Scholarships & fellowships | Acquired immune deficiency syndrome--AIDS | Councils | Microscopy | Colleges & universities | Chemical bonds | Vaccines | Grants | Viral infections
REFINEMENT | SITE | POTENT NEUTRALIZATION | RECOGNITION | BROADLY NEUTRALIZING ANTIBODIES | GP41 | IMMUNOLOGY | IDENTIFICATION | COMBINATION | BINDING | Cell Line | HIV Infections - prevention & control | Binding Sites, Antibody - immunology | env Gene Products, Human Immunodeficiency Virus - immunology | HIV Envelope Protein gp41 - immunology | Humans | Crystallization | HIV Envelope Protein gp41 - metabolism | Molecular Sequence Data | Antibodies, Neutralizing - ultrastructure | Crystallography, X-Ray | Polysaccharides - immunology | Epitopes - immunology | HIV Antibodies - ultrastructure | HIV Envelope Protein gp120 - immunology | Antibodies, Monoclonal - ultrastructure | HIV Infections - immunology | Antibodies, Neutralizing - immunology | HIV-1 - immunology | HIV Antibodies - immunology | HEK293 Cells | Protein Structure, Quaternary | Antibodies, Monoclonal - immunology | Monoclonal antibodies | Polysaccharides | HIV (Viruses) | Antigenic determinants | Proteins | Medical research | Scholarships & fellowships | Acquired immune deficiency syndrome--AIDS | Councils | Microscopy | Colleges & universities | Chemical bonds | Vaccines | Grants | Viral infections
Journal Article
VACCINES, ISSN 2076-393X, 09/2019, Volume 7, Issue 3, p. 76
The enormous sequence diversity between human immunodeficiency virus type 1 (HIV-1) strains poses a major roadblock for generating a broadly protective...
TARGET | MEDICINE, RESEARCH & EXPERIMENTAL | virus-like particles | VIRUS | GERMLINE PRECURSORS | liposomes | self-assembling protein nanoparticles | IMMUNOGEN DESIGN | IMMUNOLOGY | ENVELOPE TRIMERS | RESPONSES | PROXIMAL EXTERNAL REGION | EPITOPE | ENV TRIMERS | BINDING | HIV-1 Env
TARGET | MEDICINE, RESEARCH & EXPERIMENTAL | virus-like particles | VIRUS | GERMLINE PRECURSORS | liposomes | self-assembling protein nanoparticles | IMMUNOGEN DESIGN | IMMUNOLOGY | ENVELOPE TRIMERS | RESPONSES | PROXIMAL EXTERNAL REGION | EPITOPE | ENV TRIMERS | BINDING | HIV-1 Env
Journal Article
Journal of experimental medicine, ISSN 0022-1007, 2017, Volume 214, Issue 9, pp. 2573 - 2590
Induction of broadly neutralizing antibodies (bNAbs) by HIV-1 envelope glycoprotein immunogens would be a major advance toward an effective vaccine. A critical...
VACCINE DEVELOPMENT | MEDICINE, RESEARCH & EXPERIMENTAL | POTENT | GERMLINE PRECURSORS | RECOGNITION | AFFINITY MATURATION | IMMUNODEFICIENCY-VIRUS TYPE-1 | B-CELL-LINEAGE | BINDING-SITE | IMMUNOGEN DESIGN | IMMUNOLOGY | MONOCLONAL-ANTIBODIES | Protein Structure, Tertiary | Antibodies, Neutralizing - immunology | HIV-1 - immunology | Animals | Humans | HEK293 Cells | Protein Multimerization - immunology | Crystallography, X-Ray | HIV Envelope Protein gp160 - immunology | Mice | Gene Knock-In Techniques | Immunization | Immunoglobulins | Secretion | Glycoprotein | Reengineering | Antibodies | T cell receptors | Activation | Vaccines | CD4 antigen | Cell activation | Lymphocytes B | Neutralizing | Human immunodeficiency virus--HIV | Binding sites | Crystal structure | Conformation | 312
VACCINE DEVELOPMENT | MEDICINE, RESEARCH & EXPERIMENTAL | POTENT | GERMLINE PRECURSORS | RECOGNITION | AFFINITY MATURATION | IMMUNODEFICIENCY-VIRUS TYPE-1 | B-CELL-LINEAGE | BINDING-SITE | IMMUNOGEN DESIGN | IMMUNOLOGY | MONOCLONAL-ANTIBODIES | Protein Structure, Tertiary | Antibodies, Neutralizing - immunology | HIV-1 - immunology | Animals | Humans | HEK293 Cells | Protein Multimerization - immunology | Crystallography, X-Ray | HIV Envelope Protein gp160 - immunology | Mice | Gene Knock-In Techniques | Immunization | Immunoglobulins | Secretion | Glycoprotein | Reengineering | Antibodies | T cell receptors | Activation | Vaccines | CD4 antigen | Cell activation | Lymphocytes B | Neutralizing | Human immunodeficiency virus--HIV | Binding sites | Crystal structure | Conformation | 312
Journal Article
Acta crystallographica. Section D, Biological crystallography, ISSN 0907-4449, 2015, Volume 71, Issue Part 10, pp. 2099 - 2108
The HIV-1 envelope gp160 glycoprotein (Env) is a trimer of gp120 and gp41 heterodimers that mediates cell entry and is the primary target of the humoral immune...
SOSIP gp140 | HIV‐1 | vaccine design | glycans | broadly neutralizing antibodies | HIV-1 | BIOCHEMISTRY & MOLECULAR BIOLOGY | BIOCHEMICAL RESEARCH METHODS | ENVELOPE GLYCOPROTEIN | VULNERABILITY | CRYSTALLOGRAPHY | GP120 | POTENT | BIOPHYSICS | SEQUENCE | GLYCAN RECOGNITION | REVEALS | env Gene Products, Human Immunodeficiency Virus - immunology | HIV Infections - virology | Humans | Protein Multimerization | Models, Molecular | Crystallography, X-Ray | Polysaccharides - immunology | Epitopes - immunology | HIV Envelope Protein gp120 - immunology | HIV Infections - immunology | Antibodies, Neutralizing - immunology | HIV-1 - immunology | HIV-1 - chemistry | Antibodies, Neutralizing - chemistry | Polysaccharides - chemistry | Protein Conformation | Epitopes - chemistry | HIV Envelope Protein gp120 - chemistry | env Gene Products, Human Immunodeficiency Virus - chemistry | Polysaccharides | AIDS vaccines | Analysis | Force and energy | Crystals | HIV (Viruses) | Structure | Antigenic determinants | Neutralizing | Antibodies | Evolution | Trimers | Vaccines | Shields | Glycan | Crystal structure
SOSIP gp140 | HIV‐1 | vaccine design | glycans | broadly neutralizing antibodies | HIV-1 | BIOCHEMISTRY & MOLECULAR BIOLOGY | BIOCHEMICAL RESEARCH METHODS | ENVELOPE GLYCOPROTEIN | VULNERABILITY | CRYSTALLOGRAPHY | GP120 | POTENT | BIOPHYSICS | SEQUENCE | GLYCAN RECOGNITION | REVEALS | env Gene Products, Human Immunodeficiency Virus - immunology | HIV Infections - virology | Humans | Protein Multimerization | Models, Molecular | Crystallography, X-Ray | Polysaccharides - immunology | Epitopes - immunology | HIV Envelope Protein gp120 - immunology | HIV Infections - immunology | Antibodies, Neutralizing - immunology | HIV-1 - immunology | HIV-1 - chemistry | Antibodies, Neutralizing - chemistry | Polysaccharides - chemistry | Protein Conformation | Epitopes - chemistry | HIV Envelope Protein gp120 - chemistry | env Gene Products, Human Immunodeficiency Virus - chemistry | Polysaccharides | AIDS vaccines | Analysis | Force and energy | Crystals | HIV (Viruses) | Structure | Antigenic determinants | Neutralizing | Antibodies | Evolution | Trimers | Vaccines | Shields | Glycan | Crystal structure
Journal Article
PLoS pathogens, ISSN 1553-7366, 2015, Volume 11, Issue 3, pp. 1 - 22
The trimeric envelope (Env) spike is the focus of vaccine design efforts aimed at generating broadly neutralizing antibodies (bNAbs) to protect against HIV-1...
MICROBIOLOGY | DEPENDENT EPITOPE | GP41-GP120 INTERFACE | POTENT | VIROLOGY | BROADLY NEUTRALIZING ANTIBODIES | GLYCOPROTEIN COMPLEX | IMMUNODEFICIENCY-VIRUS TYPE-1 | ENV TRIMERS | BINDING-SITE | CD4 BINDING | MONOCLONAL-ANTIBODIES | PARASITOLOGY | Epitope Mapping | Gene Products, env - immunology | HIV Antibodies - chemistry | Epitopes - immunology | Antibodies, Neutralizing - immunology | HIV-1 - immunology | HIV Antibodies - immunology | HIV Antigens - immunology | Gene Products, env - chemistry | HIV-1 - chemistry | Antibodies, Neutralizing - chemistry | HIV Antigens - chemistry | Epitopes - chemistry | Competition | Acquired immune deficiency syndrome | Microscopy | AIDS | Vaccines | Grants | Experiments
MICROBIOLOGY | DEPENDENT EPITOPE | GP41-GP120 INTERFACE | POTENT | VIROLOGY | BROADLY NEUTRALIZING ANTIBODIES | GLYCOPROTEIN COMPLEX | IMMUNODEFICIENCY-VIRUS TYPE-1 | ENV TRIMERS | BINDING-SITE | CD4 BINDING | MONOCLONAL-ANTIBODIES | PARASITOLOGY | Epitope Mapping | Gene Products, env - immunology | HIV Antibodies - chemistry | Epitopes - immunology | Antibodies, Neutralizing - immunology | HIV-1 - immunology | HIV Antibodies - immunology | HIV Antigens - immunology | Gene Products, env - chemistry | HIV-1 - chemistry | Antibodies, Neutralizing - chemistry | HIV Antigens - chemistry | Epitopes - chemistry | Competition | Acquired immune deficiency syndrome | Microscopy | AIDS | Vaccines | Grants | Experiments
Journal Article
Nature communications, ISSN 2041-1723, 2015, Volume 6, Issue 1, p. 8167
The recent identification of three broadly neutralizing antibodies (bnAbs) against gp120-gp41 interface epitopes has expanded the targetable surface on the...
PROXIMAL EXTERNAL-REGION | POTENT NEUTRALIZATION | BROAD NEUTRALIZATION | RECOGNITION | TRIMERS | MULTIDISCIPLINARY SCIENCES | ENVELOPE | VACCINE | BINDING-SITE | CRYO-EM STRUCTURE | DEPENDENT EPITOPE | Epitope Mapping | HIV Envelope Protein gp41 - immunology | Humans | Models, Molecular | Crystallography, X-Ray | Epitopes | Cryoelectron Microscopy | HIV Envelope Protein gp120 - immunology | Antibodies, Neutralizing - immunology | HIV-1 - immunology | HIV Antibodies - immunology | Immunoglobulin G - immunology | Computer Simulation | HEK293 Cells | Protein Conformation | Immunoglobulin Fab Fragments - immunology | Antibodies, Neutralizing | HIV-1 | Immunoglobulin G | HIV Antibodies | Biochemistry, Molecular Biology | HIV Envelope Protein gp120 | HIV Envelope Protein gp41 | Life Sciences | Biomolecules | Immunoglobulin Fab Fragments
PROXIMAL EXTERNAL-REGION | POTENT NEUTRALIZATION | BROAD NEUTRALIZATION | RECOGNITION | TRIMERS | MULTIDISCIPLINARY SCIENCES | ENVELOPE | VACCINE | BINDING-SITE | CRYO-EM STRUCTURE | DEPENDENT EPITOPE | Epitope Mapping | HIV Envelope Protein gp41 - immunology | Humans | Models, Molecular | Crystallography, X-Ray | Epitopes | Cryoelectron Microscopy | HIV Envelope Protein gp120 - immunology | Antibodies, Neutralizing - immunology | HIV-1 - immunology | HIV Antibodies - immunology | Immunoglobulin G - immunology | Computer Simulation | HEK293 Cells | Protein Conformation | Immunoglobulin Fab Fragments - immunology | Antibodies, Neutralizing | HIV-1 | Immunoglobulin G | HIV Antibodies | Biochemistry, Molecular Biology | HIV Envelope Protein gp120 | HIV Envelope Protein gp41 | Life Sciences | Biomolecules | Immunoglobulin Fab Fragments
Journal Article
Retrovirology, ISSN 1742-4690, 2015, Volume 12, Issue 1, p. 82
Background: Presenting vaccine antigens in particulate form can improve their immunogenicity by enhancing B cell activation. Findings: We describe...
HIV-1 | Nanoparticles | BG505 | Ferritin | SOSIP | Vaccine | Envelope glycoprotein | VIROLOGY | GLYCOPROTEIN COMPLEX | GP41 | DEPENDENT EPITOPE | VACCINES | Rabbits | Immunization | env Gene Products, Human Immunodeficiency Virus - immunology | Ferritins - immunology | Humans | Protein Multimerization | AIDS Vaccines - immunology | AIDS Vaccines - chemistry | HIV-1 - immunology | Animals | Antibodies, Neutralizing - biosynthesis | HIV-1 - chemistry | HIV Antibodies - biosynthesis | Female | Mice | env Gene Products, Human Immunodeficiency Virus - chemistry | Viral antibodies | Antigens | AIDS vaccines | Immune response | Antibodies | Air pollution | HIV (Viruses)
HIV-1 | Nanoparticles | BG505 | Ferritin | SOSIP | Vaccine | Envelope glycoprotein | VIROLOGY | GLYCOPROTEIN COMPLEX | GP41 | DEPENDENT EPITOPE | VACCINES | Rabbits | Immunization | env Gene Products, Human Immunodeficiency Virus - immunology | Ferritins - immunology | Humans | Protein Multimerization | AIDS Vaccines - immunology | AIDS Vaccines - chemistry | HIV-1 - immunology | Animals | Antibodies, Neutralizing - biosynthesis | HIV-1 - chemistry | HIV Antibodies - biosynthesis | Female | Mice | env Gene Products, Human Immunodeficiency Virus - chemistry | Viral antibodies | Antigens | AIDS vaccines | Immune response | Antibodies | Air pollution | HIV (Viruses)
Journal Article
11.
Full Text
Improving the Immunogenicity of Native-like HIV-1 Envelope Trimers by Hyperstabilization
Cell Reports, ISSN 2211-1247, 08/2017, Volume 20, Issue 8, pp. 1805 - 1817
The production of native-like recombinant versions of the HIV-1 envelope glycoprotein (Env) trimer requires overcoming the natural flexibility and instability...
TARGET | DISULFIDE BONDS | BROADLY NEUTRALIZING ANTIBODIES | GLYCOPROTEIN COMPLEX | GLYCOSYLATION | CRYO-EM STRUCTURE | CELL BIOLOGY
TARGET | DISULFIDE BONDS | BROADLY NEUTRALIZING ANTIBODIES | GLYCOPROTEIN COMPLEX | GLYCOSYLATION | CRYO-EM STRUCTURE | CELL BIOLOGY
Journal Article